Safety, Tolerability, and Efficacy of Vortioxetine (Lu AA21004) in Major Depressive Disorder

International Clinical Psychopharmacology - United States
doi 10.1097/yic.0000000000000010
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Safety and Tolerability of Desvenlafaxine in Children and Adolescents With Major Depressive Disorder

Journal of Child and Adolescent Psychopharmacology
Mental HealthChild HealthPharmacologyPerinatologyPsychiatryPediatrics
2014English

Efficacy and Tolerability of Mirtazapine Versus Paroxetine in the Treatment of Major Depressive Disorder

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2012English

Efficacy, Safety and Tolerability of Escitalopram in Doses Up to 50 Mg in Major Depressive Disorder (MDD): An Open-Label, Pilot Study

BMC Psychiatry
PsychiatryMental Health
2011English

Erratum To: Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results From an Open-Label, 48-Week Extension Study

Clinical Drug Investigation
MedicinePharmacology
2013English

Major Depressive Disorder

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2018English

Safety and Tolerability of Edivoxetine as Adjunctive Treatment to Selective Serotonin Reuptake Inhibitor Antidepressants for Patients With Major Depressive Disorder

Drugs in Context
Molecular MedicinePharmacology
2015English

Tolerability and Safety Profile of Cariprazine in Treating Psychotic Disorders, Bipolar Disorder and Major Depressive Disorder: A Systematic Review With Meta-Analysis of Randomized Controlled Trials

CNS Drugs
PsychiatryMental HealthNeurologyPharmacology
2016English

Major Depressive Disorder

English

Major Depressive Disorder

2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy